[1] Wyatt RM,Fraser I,Welty N,Lord B,Wennerholm M,Sutton S,Ameriks MK,Dugovic C,Yun S,White A,Nguyen L,Koudriakova T,Tian G,Suarez J,Szewczuk L,Bonnette W,Ahn K,Ghosh B,Flores CM,Connolly PJ,Zhu B,Macielag MJ,Brandt MR,Chevalier K,Zhang SP,Lovenberg T,Bonaventure P.Pharmacologic Characterization of JNJ-42226314,[1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone,a Reversible,Selective,and Potent Monoacylglycerol Lipase Inhibitor.J Pharmacol Exp Ther.2020 Mar;372(3):339-353.doi:10.1124/jpet.119.262139.Epub 2019 Dec 9.PMID:31818916.